NuCana plc has announced the appointment of Theresa Bruce as Chief Operating Officer, effective January 1, 2026. Theresa brings over two decades of experience in global clinical development to the role.
Company Information
Company
NuCana
Location
Edinburgh, Scotland, United Kingdom
About
NuCana is a clinical-stage biopharmaceutical company developing safer and more effective cancer treatments by applying its proprietary ProTide technology to transform widely used chemotherapy agents. With a pipeline that includes NUC-7738 and NUC-3373, NuCana aims to overcome the limitations of conventional nucleoside analogs and improve outcomes for patients with solid and hematological tumors.
Fundz sees it the moment NuCana changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
EdinburghBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical